C1orf50 and breast carcinoma: Immunostaining with anti-YAP/TAZ, anti-C1orf50, and anti-NANOG antibodies in tissue arrays showed that C1orf50-high breast cancer cells express YAP/TAZ and NANOG at high levels in Luminal breast cancer cells (Fig. 5B).